# Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With End Stage Renal Disease Receiving Dialysis

> **NCT00151931** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 456 (—)

## Conditions studied

- Kidney Failure, Chronic

## Interventions

- **DRUG:** Lanthanum carbonate

## Key facts

- **NCT ID:** NCT00151931
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05-11
- **Primary completion:** 2006-01-12
- **Final completion:** 2006-01-12
- **Target enrollment:** 456 (—)
- **Last updated:** 2021-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00151931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00151931, "Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With End Stage Renal Disease Receiving Dialysis". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00151931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*